Design and optimization of a new series of HSP70 inhibitors for use in the treatment of pancreatic cancer.

被引：0
|
作者：
Maxwell, David S. [1 ]
Sun, Duoli [1 ]
Peng, Zhenghong [1 ]
Qi, Wei [1 ]
McConkey, David [1 ]
Abbruzzese, James L. [1 ]
Bornmann, William G. [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2013年 / 12卷 / 11期
关键词：
D O I：
10.1158/1535-7163.TARG-13-B101
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B101
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Radiofrequency ablation in combination with an mTOR inhibitor restrains pancreatic cancer growth induced by intrinsic HSP70
    Gao, Shanshan
    Pu, Ning
    Yin, Hanlin
    Li, Junhao
    Chen, Qiangda
    Yang, Minjie
    Lou, Wenhui
    Chen, Yi
    Zhou, Guofeng
    Li, Changyu
    Li, Guoping
    Yan, Zhiping
    Liu, Lingxiao
    Yu, Jun
    Wang, Xiaolin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [32] The HSP70 and Autophagy Inhibitor Pifithrin-μ Enhances the Antitumor Effects of TRAIL on Human Pancreatic Cancer
    Monma, Hiroyuki
    Harashima, Nanae
    Inao, Touko
    Okano, Shinji
    Tajima, Yoshitsugu
    Harada, Mamoru
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (04) : 341 - 351
  • [33] Identifying synthetic lethal interactions in castration-resistant prostate cancer using HSP40 and HSP70 inhibitors
    Moses, Michael A.
    Rivera-Marquez, Genesis
    Taylor, Isabelle
    Shao, Hao
    Gestwicki, Jason
    Trepel, Jane
    Neckers, Len
    CANCER RESEARCH, 2018, 78 (13)
  • [34] Serum HSP70 and VEGF Levels Are Effective Predictive Factors of Chemoradiosensitivity and Prognosis of Pancreatic Cancer Patients
    Xiong, Liumei
    Li, Danming
    Xiao, Gui
    Tan, Sipin
    Wen, Jianbo
    Wang, Guiliang
    PANCREAS, 2024, 53 (09) : e713 - e722
  • [35] Sensitizing tumor cells to conventional drugs: HSP70 chaperone inhibitors, their selection and application in cancer models
    Vladimir F. Lazarev
    Dmitry V. Sverchinsky
    Elena R. Mikhaylova
    Pavel I. Semenyuk
    Elena Y. Komarova
    Sergey A. Niskanen
    Alina D. Nikotina
    Anton V. Burakov
    Viktor G. Kartsev
    Irina V. Guzhova
    Boris A. Margulis
    Cell Death & Disease, 9
  • [36] Hsp70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells
    Tanaka, Masako
    Shiota, Masayuki
    CANCER SCIENCE, 2018, 109 : 580 - 580
  • [37] Sensitizing tumor cells to conventional drugs: HSP70 chaperone inhibitors, their selection and application in cancer models
    Lazarev, Vladimir F.
    Sverchinsky, Dmitry V.
    Mikhaylova, Elena R.
    Semenyuk, Pavel I.
    Komarova, Elena Y.
    Niskanen, Sergey A.
    Nikotina, Alina D.
    Burakov, Anton V.
    Kartsev, Viktor G.
    Guzhova, Irina V.
    Margulis, Boris A.
    CELL DEATH & DISEASE, 2018, 9
  • [38] Hsp70 response to 5-fluorouracil treatment in human colon cancer cell lines
    Grivicich, Ivana
    Regner, Andrea
    Zanoni, Caroline
    Correa, Larissa Procopio
    Jotz, Geraldo Pereira
    Henriques, Joao Antonio Pegas
    Schwartsmann, Gilberto
    da Rocha, Adriana Brondani
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2007, 22 (10) : 1201 - 1208
  • [39] Hsp70 response to 5-fluorouracil treatment in human colon cancer cell lines
    Ivana Grivicich
    Andréa Regner
    Caroline Zanoni
    Larissa Procópio Correa
    Geraldo Pereira Jotz
    João Antônio Pêgas Henriques
    Gilberto Schwartsmann
    Adriana Brondani da Rocha
    International Journal of Colorectal Disease, 2007, 22 : 1201 - 1208
  • [40] HSP70 Inhibition Limits FAK-Dependent Invasion and Enhances the Response to Melanoma Treatment with BRAF Inhibitors
    Budina-Kolomets, Anna
    Webster, Marie R.
    Leu, Julia I-Ju
    Jennis, Matthew
    Krepler, Clemens
    Guerrini, Anastasia
    Kossenkov, Andrew V.
    Xu, Wei
    Karakousis, Giorgos
    Schuchter, Lynn
    Amaravadi, Ravi K.
    Wu, Hong
    Yin, Xiangfan
    Liu, Qin
    Lu, Yiling
    Mills, Gordon B.
    Xu, Xiaowei
    George, Donna L.
    Weeraratna, Ashani T.
    Murphy, Maureen E.
    CANCER RESEARCH, 2016, 76 (09) : 2720 - 2730
12345